Data Sources
Articles for this review were identified through searches of MEDLINE (January 1965–April 2010) using the search terms induction therapy, renal transplantation, antithymocyte globulin rabbit, antithymocyte globulin horse, muromonab-CD3, basiliximab, daclizumab, and alemtuzumab. Bibliographies of articles retrieved were also reviewed for relevant trials. Clinical trials were included if they involved renal transplant recipients, included a control group, and were deemed to be of moderate-to-high quality. All English-language in vitro and in vivo studies evaluating induction therapy agents were also reviewed and considered for inclusion.
Am J Health Syst Pharm. 2011;68(3):211-218. © 2011 American Society of Health-System Pharmacists, Inc.
All rights reserved. Posted with permission.
Cite this: Induction Immunosuppressive Therapies in Renal Transplantation - Medscape - Feb 01, 2011.
Comments